Metraipolis › archive › dc_abdd382401ac

Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for… — Europe PMC PMID:40999385

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40999385
DOI: 10.1186/s12865-[numero omesso]-2
License (as archived): solo-consultazione
Archived: 2026-11-09T18:17:31.594Z
SHA-256 of the archived text: f7659f4ad7fcccb81007f8763ec24eb1d17f2123bba15b6178aa4445c70a9d48
Stable URL of this page: https://metraipolis.com/documento/dc_abdd382401ac

How to cite

Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for… — Europe PMC PMID:40999385 — Europe PMC (en), https://europepmc.org/article/MED/40999385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_abdd382401ac (Metraipolis archive dc_abdd382401ac, sha256 f7659f4ad7fcccb81007f8763ec24eb1d17f2123bba15b6178aa4445c70a9d48)

BibTeX

@misc{dcabdd382401ac,
  title = {Enfortumab vedotin promotes PD-L1 expression in urothelial carcinoma via NF-κB and STAT3 pathways highlighting mechanisms of immune evasion and potential for… — Europe PMC PMID:40999385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40999385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_abdd382401ac; sha256 f7659f4ad7fcccb81007f8763ec24eb1d17f2123bba15b6178aa4445c70a9d48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40999385. Agents can read the archived copy with the MCP tool read_document.